U.S. Other Utilities Stock News

Event context and recent share performance BOK Financial (BOKF) shares slipped around 2.6% in the latest session, even as the stock shows gains over the past week, month and past 3 months. That mix of moves has investors reassessing the regional bank's recent performance and valuation. See our latest analysis for BOK Financial. That 2.6% one day share price drop comes after a stronger run, with a 90 day share price return of 24.31% and a 1 year total shareholder return of 22.90%. This hints...

Crown Holdings recently reported continued operational strength, with consecutive earnings beats, upwardly revised guidance, and US$233 million of Q1 2025 share repurchases already executed. Beyond near-term results, management’s emphasis on efficiency gains, sustainable supply chains, and disciplined leverage targets is shaping expectations ahead of upcoming Q4 2025 earnings and 2026 guidance updates. Next, we’ll examine how Crown Holdings’ ongoing focus on operational efficiencies could...

DocuSign (DOCU) just rolled out new AI assisted eSignature tools that summarize contracts in plain language and automate field placement, sharpening the focus on how this product shift might matter for the stock. See our latest analysis for DocuSign. Despite the product rollout, DocuSign’s recent 30 day share price return of 17.49% and 90 day share price return of 19.63% point to fading momentum. The 1 year total shareholder return decline of 37.27% highlights longer term pressure that this...

Rubrik recently launched Rubrik Security Cloud Sovereign, a data protection platform that keeps all data, metadata, and control functions within customer-defined borders while offering immutable protection, sovereign-compatible threat detection, and multiple deployment options across sovereign cloud providers and on-premises infrastructure. This move positions Rubrik to address tightening global data-sovereignty rules by giving organizations granular control over where sensitive information...

Definium Therapeutics (DFTX) has drawn fresh attention after launching its Rerouting Minds campaign, an educational push on pharmaceutical LSD for severe mental health disorders that ties directly into its late stage psychedelic medicine programs. See our latest analysis for Definium Therapeutics. The recent Rerouting Minds launch, together with Definium’s rebrand from Mind Medicine and ticker change to DFTX, coincides with strong share price momentum, including a 29.56% 30 day share price...

The White House has proposed a cap on U.S. credit card interest rates that would apply across major issuers. If adopted, the cap could affect how American Express (NYSE:AXP) prices revolving credit and manages cardholder risk. The proposal targets annual percentage rates on consumer credit cards, a core revenue source for issuers. For American Express, which combines a payments network with a lending business, any limit on credit card APRs goes straight to how its model works. The company...

How Athena could matter for RealReal stock The RealReal (REAL) recently rolled out its Athena system, a technology that helps validate luxury goods and shorten the time from item drop off to online listing. This development has put operational efficiency in sharper focus for investors. See our latest analysis for RealReal. Despite the Athena launch sharpening the focus on efficiency, RealReal’s recent share price performance has been mixed, with a 7 day share price return of 8.26% and a 90...

Why Clover Health is Back on Investors’ Radar Recent analyst commentary on Clover Health Investments (CLOV) has focused on three main areas: rapid Medicare Advantage membership growth, operational improvements, and management’s expectation of achieving GAAP profitability in 2026. See our latest analysis for Clover Health Investments. At a share price of US$2.59, Clover Health has seen a 7.47% year to date share price return and a 2.37% 1 month share price return, but a 32.20% 3 month share...

Corvus Pharmaceuticals (CRVS) is back in focus after early trial data for its oral eczema drug, soquelitinib, showed meaningful clinical benefit and a clean safety profile, followed by a sizeable equity raise to fund further development. See our latest analysis for Corvus Pharmaceuticals. The share price has surged over the past month, with a 30 day share price return of 235.56% and a 1 year total shareholder return of 375.38%. This suggests momentum has been building around the eczema data...

If you are wondering whether JPMorgan Chase is attractively priced or already fully valued, you are not alone. This article is designed to help you frame that question clearly. The stock last closed at US$297.72, with a 7 day return of a 4.7% decline, a 30 day return of a 9.6% decline, a year to date return of an 8.5% decline, a 1 year return of 14.7%, a 3 year return of 127.8% and a 5 year return of 162.7%. Recent market attention has been shaped by ongoing macro and regulatory headlines...

Patria Investments, ticker NasdaqGS:PAX, has recently drawn attention after an upward revision in earnings estimates. The company now holds a top Zacks Rank, reflecting a stronger view from analysts on its near term prospects. The current share price stands at $17.15, with the stock up 48.0% over the past year. For investors tracking performance, Patria Investments has seen a 7.5% return over the past 30 days and a 48.0% return over the past year, with shares at $17.15. Over longer...

CompoSecure has rebranded as GPGI and is now trading under a new ticker on the NYSE, reflecting a broader corporate identity. Graham Robinson has been appointed President and CEO, alongside changes to the board and the company’s independent auditor. GPGI has completed a major business combination with Husky Technologies, forming a diversified platform with multiple business segments. GPGI, now listed as NYSE:CMPO, is trading at a share price of $25.05. Over the last three years, the stock...

If you are wondering whether Rocket Lab's share price still makes sense after such a strong run, you are not alone. This article looks squarely at what the stock might be worth. The stock has seen a 7.7% decline over the last 7 days, alongside a 15.2% gain over 30 days, 17.0% year to date and very large multi year returns of 192.8% over 1 year, 7x over 3 years and more than 7x over 5 years. Recent news coverage has focused on Rocket Lab's role as a listed launch and space technology company...

Trip.com Group (TCOM) has come under closer scrutiny after receiving a notice of investigation from China’s State Administration for Market Regulations under the Anti Monopoly Law, prompting multiple law firms to launch shareholder probes. See our latest analysis for Trip.com Group. Those regulatory headlines have arrived after a weaker stretch for the stock, with a 30 day share price return of a 12.96% decline and a year to date share price return of a 15.59% decline. However, the 3 year...

If you are wondering whether lululemon athletica's current share price reflects its true worth, you are not alone. This article focuses squarely on what the latest numbers say about value. The stock recently closed at US$191.07, after returns of a 5.3% decline over 7 days, 9.2% decline over 30 days, and 9.4% decline year to date, with a 52.2% decline over 1 year, 38.5% decline over 3 years, and 41.9% decline over 5 years. Recent coverage around lululemon has focused on how the share price...

In January 2026, BioNTech outlined progress on its 2026 plan to evolve into a multi-product oncology company, highlighting more than 25 ongoing Phase 2 or 3 trials and intentions to launch six additional Phase 3 studies this year. The company’s emphasis on pan-tumor assets, novel-novel combination regimens, and a roadmap to at least 17 late-stage data readouts by 2030+ underscores an effort to build a broad, clinically driven cancer franchise across major tumor types in partnership with...

Mexico has acquired Latin America's first Lockheed Martin C-130J-30 Super Hercules tactical airlifter. The deal marks a new phase for regional airlift capabilities and expands Lockheed Martin's international footprint. The C-130J-30 is expected to serve roles such as transport, humanitarian missions, and disaster response across Mexico and the wider region. For investors watching Lockheed Martin (NYSE:LMT), Mexico's decision highlights fresh interest in the company's airlift platforms...

Clorox stock snapshot after recent performance shift Clorox (CLX) has drawn fresh attention after a strong month, with the share price up about 15.5%, even as the past 3 months and 1 year show negative total returns. See our latest analysis for Clorox. The recent 1 month share price return of 15.55% contrasts with a weaker 1 year total shareholder return of a 26.08% decline, suggesting improving short term momentum after a tougher stretch for long term holders. If Clorox's rebound has you...

Recent analyst commentary on Independence Realty Trust (IRT) has become more mixed, as bullish views from Citizens JMP and UBS now meet a hold downgrade from Deutsche Bank. This shift places the REIT more squarely under investor scrutiny. See our latest analysis for Independence Realty Trust. At a share price of $16.84, Independence Realty Trust has seen mixed momentum, with a 90 day share price return of 3.57% but a 1 year total shareholder return decline of 6.88%. This suggests sentiment...

Earlier in January 2026, CleanSpark, Inc. announced an agreement to acquire up to 447 acres in Brazoria County, Texas, to build a large-scale AI and high-performance computing data center with an initial 300 MW of power and potential expansion to 600 MW, subject to utility and property approvals. This move, combined with its earlier Austin County development, marks a significant effort to build a regional power and infrastructure hub in the ERCOT Greater Houston area with more than 890 MW of...

In recent days, ConocoPhillips has come under pressure from several major banks, including JPMorgan and Bank of America, which downgraded the stock after raising concerns about its relatively high oil breakeven costs and weaker free cash flow metrics versus peers. These moves shine a light on ConocoPhillips’ heavy commitment to long-cycle projects such as Willow and Port Arthur LNG, whose multi-year timelines and rising costs are prompting fresh questions about the balance between future...

If you are wondering whether Planet Fitness shares offer good value at today's price, or if the recent moves suggest caution, this article will walk you through what the numbers say. The stock closed at US$94.47, with returns of a 3.3% decline over 7 days, a 14.1% decline over 30 days, a 13.9% decline year to date, a 9.9% decline over 1 year, 14.7% over 3 years and 31.2% over 5 years, which provides a mixed picture depending on how far back you look. Recent headlines around Planet Fitness...

If you are wondering whether Nasdaq's share price still offers value or if the easy gains are behind it, starting with the recent return profile can help frame the question clearly. The stock last closed at US$98.05, with returns of 22.3% over 1 year, 69.1% over 3 years, and 132.8% over 5 years. In the shorter term, it shows a 2.9% decline over 7 days and a 0.6% decline over 30 days, alongside a 1.4% gain year to date. Recent news coverage around Nasdaq has focused on its role as a global...

Burlington Stores recently reported quarterly results showing a 7.1% year-on-year revenue increase and an EBITDA outcome above analyst estimates, while offering slightly softer revenue guidance for the upcoming quarter. Management highlighted that comparable store sales rose 1% despite weather-related traffic headwinds, and that Burlington lagged its off-price peers on revenue growth even as performance still improved. We’ll now examine how Burlington’s revenue growth alongside an EBITDA...